ArTS Archivio della ricerca di Trieste

TEDESCO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.016
EU - Europa 18.224
AS - Asia 15.517
SA - Sud America 5.065
AF - Africa 628
OC - Oceania 403
Continente sconosciuto - Info sul continente non disponibili 19
Totale 66.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.792
CN - Cina 5.472
IT - Italia 4.829
BR - Brasile 2.990
DE - Germania 2.045
SG - Singapore 1.838
ES - Italia 1.577
GB - Regno Unito 1.310
MX - Messico 1.299
PL - Polonia 1.241
JP - Giappone 1.191
IN - India 1.082
FR - Francia 1.060
TR - Turchia 1.010
SE - Svezia 948
HK - Hong Kong 774
ID - Indonesia 772
UA - Ucraina 702
CA - Canada 686
VN - Vietnam 664
NL - Olanda 556
KR - Corea 531
RU - Federazione Russa 518
CO - Colombia 484
PT - Portogallo 473
AR - Argentina 465
TW - Taiwan 452
FI - Finlandia 444
PE - Perù 389
GR - Grecia 353
CL - Cile 346
AU - Australia 334
AT - Austria 268
TH - Thailandia 261
CH - Svizzera 253
BE - Belgio 237
EC - Ecuador 217
IE - Irlanda 207
RO - Romania 199
SA - Arabia Saudita 196
DK - Danimarca 167
PK - Pakistan 161
EG - Egitto 146
IR - Iran 141
BG - Bulgaria 137
BD - Bangladesh 119
CZ - Repubblica Ceca 118
IL - Israele 116
MY - Malesia 101
MA - Marocco 99
PH - Filippine 96
HU - Ungheria 91
ZA - Sudafrica 89
IQ - Iraq 78
HR - Croazia 75
SI - Slovenia 69
RS - Serbia 67
NZ - Nuova Zelanda 66
TN - Tunisia 61
VE - Venezuela 61
LB - Libano 53
LT - Lituania 53
PA - Panama 52
NO - Norvegia 50
LV - Lettonia 47
AE - Emirati Arabi Uniti 41
BO - Bolivia 39
CR - Costa Rica 39
JO - Giordania 38
GT - Guatemala 36
KZ - Kazakistan 36
NG - Nigeria 36
UY - Uruguay 36
SK - Slovacchia (Repubblica Slovacca) 35
DZ - Algeria 34
UZ - Uzbekistan 31
PY - Paraguay 30
NP - Nepal 27
QA - Qatar 27
HN - Honduras 26
LK - Sri Lanka 26
PS - Palestinian Territory 23
SY - Repubblica araba siriana 21
OM - Oman 20
SN - Senegal 20
BY - Bielorussia 19
GE - Georgia 19
CY - Cipro 18
EE - Estonia 17
KE - Kenya 17
DO - Repubblica Dominicana 16
ET - Etiopia 16
NI - Nicaragua 16
AZ - Azerbaigian 15
KW - Kuwait 12
BA - Bosnia-Erzegovina 11
LU - Lussemburgo 11
PR - Porto Rico 11
RE - Reunion 11
SV - El Salvador 11
Totale 66.619
Salva come PNG Salva come JPEG
Città #
Ashburn 9.237
Fairfield 1.260
Woodbridge 1.179
Singapore 1.170
Ann Arbor 1.039
Germantown 1.013
Houston 914
Warsaw 787
Chandler 625
Milan 620
Beijing 611
Jacksonville 593
Wilmington 570
San Jose 569
Seattle 567
Rome 546
São Paulo 511
Dallas 478
Hong Kong 477
Munich 468
Cambridge 434
Trieste 422
Madrid 406
Shanghai 365
Guangzhou 341
Tokyo 323
Los Angeles 308
Istanbul 304
Seoul 280
Chicago 277
Hefei 264
Lima 250
Rio de Janeiro 250
New York 249
Barcelona 247
Paris 240
Princeton 229
Ho Chi Minh City 221
Frankfurt am Main 214
Bogotá 210
Hangzhou 203
Hanoi 192
Athens 185
Helsinki 185
Buenos Aires 184
Dublin 184
Santiago 181
Taipei 181
Boardman 174
Jakarta 171
Lisbon 169
Izmir 168
Moscow 167
Vienna 157
Ankara 156
Montréal 151
Naples 151
Chengdu 146
Mcallen 143
Bangkok 139
Turin 139
Bologna 136
Columbus 136
Bengaluru 133
The Dalles 129
Amsterdam 127
Florence 126
London 123
Sofia 121
Curitiba 115
Nanjing 115
Brasília 110
Berlin 106
Mumbai 104
Medellín 103
Toronto 103
Chennai 102
Hyderabad 102
Melbourne 100
Zurich 100
Washington 99
Buffalo 98
Las Vegas 97
Valencia 97
Zgierz 96
Lauterbourg 94
Wuhan 93
Montreal 92
San Diego 92
Quito 90
Sydney 90
Belo Horizonte 89
Council Bluffs 89
Guadalajara 89
Porto Alegre 89
Copenhagen 88
Thessaloniki 88
Verona 88
Brussels 87
Benito Juarez 86
Totale 36.616
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.781
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications 772
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 414
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 402
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 348
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 343
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 339
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats 322
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 316
Complement as a biological tool to control tumor growth 316
C1q is involved in human trophoblast invasion 304
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 299
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 288
C1q is associated with a reduced inflammatory response of decidual endothelial cells 287
Targeted nanoparticles and complement activation 282
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 273
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 267
C1q: A novel angiogenic factor? 265
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 258
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 255
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 254
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 254
Placental trophoblast and endothelial cells as target of maternal immune response. 236
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 231
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 230
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 227
Complement as effector system in cancer immunotherapy. 224
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 223
Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. 223
Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules 219
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma. 218
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 215
Bactericidal activities of human polymorphonuclear leukocyte proteins against Escherichia coli 0111:B4 coated with C5 or C8 204
Preeclampsia is associated with defective production of C1q by invasive trophoblast 204
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. 201
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 200
OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis 195
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. 194
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 193
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy 193
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 192
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 192
Complement in human diseases: Lessons from complement deficiencies. 189
Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. 187
Inherited complement deficiencies and bacterial infections. 186
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 185
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 183
Complement activation in animal and human pregnancies as a model for immunological recognition 182
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 175
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 174
The Complement System at the Embryo Implantation Site: Friend or Foe? 173
Chacterization of soluble terminal complement complex assembled in C8ß-deficient plasma and serum 170
Analysis of the molecular mechanisms of C1-inhibitor deficiency induced angioedema 170
Biological response of B lymphoma cells to anti-CD20 monoclonal antibody Rituximab in vitro: CD55 and CD59 regulate complement mediated lysis. 169
FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis 168
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. 166
Cross-talk between the complement and the kinin system in vascular permeability 166
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma. 165
Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement. 163
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 161
Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule 160
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 160
Humoral immunotherapy of multiple myeloma: perspectives and perplexities. 159
null 159
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 159
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. 157
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 157
null 155
null 154
C1q induces in vivo angiogenesis and promotes wound healing 153
null 151
Role of the B1 Bradykinin Receptor and gC1qR/p33 in Angioedema 151
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 150
Hepatocyte nuclear factor 1a controls the expression of terminal complement genes 150
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. 150
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 149
The development of atypical hemolytic uremic syndrome depends on complement C5. 149
Feto-maternal immune interaction at the placental level 149
Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. 147
Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation 146
An elctrophysiological study of the effects of myasthenia gravis sera and complement on rat isolated muscle fibres. 144
The membrane attack complex of complement induces caspase activation and apoptosis. 141
Protection against inflammation- and antiphospholipid antibody-caused fetal loss by the chemokine decoy receptor D6 141
The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. 139
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 137
Complement production by trophoblast cells at the feto-maternal interface. 136
Pathophysiological consequences of complement-endothelial cell interaction 135
Complement-endothelial cell interaction: pathophysiological implications. 133
Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex 133
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 132
INTRACEREBROVENTRICULAR INJECTION OF THE TERMINAL COMPLEMENT COMPLEX CAUSES INFLAMMATORY REACTION IN THE RAT BRAIN 131
Inflammatory response and the endothelium 128
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. 123
null 121
null 121
null 121
null 119
Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. 116
Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose 112
null 110
Totale 64.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.322 57 77 73 121 40 132 62 43 146 156 90 325
2022/20231.845 185 248 146 269 142 358 6 158 233 5 70 25
2023/20241.012 65 53 64 33 154 137 153 177 19 15 83 59
2024/202520.722 29 34 137 171 208 245 281 196 356 219 5.897 12.949
2025/202631.785 5.643 4.908 5.655 5.178 5.087 2.347 883 184 730 727 266 177
2026/20279 9 0 0 0 0 0 0 0 0 0 0 0
Totale 67.177